NCT03263780View on ClinicalTrials.gov

High Resolution PET-MRI Before Prostate Cancer HIFU

PHASE2CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

January 8, 2020

Study Completion Date

January 8, 2020

Conditions

Prostate Cancer

Interventions

DRUG

18F-Fluciclovine

Imaging (comparing standard and experimental high resolution diffusion-weighted imaging \[DWI\] MRI with 18F-Fluciclovine)

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

Sponsors

Collaborators (1)

Blue Earth Diagnostics

All Listed Sponsors

collaborator

Blue Earth Diagnostics

INDUSTRY

lead

Timothy J. Daskivich

OTHER

NCT03263780 - High Resolution PET-MRI Before Prostate Cancer HIFU | Biotech Hunter | Biotech Hunter